Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684422 · ClinicalTrials.gov registry record
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 48
- Enrollment target
NCT02684422: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02684422 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02684422 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
This study aims to examine features of MRSA that are associated with chronic MRSA infection and bacterial persistence despite IV antibiotic therapy. Subjects are asked to expectorate sputum and complete CF symptom diaries both at beginning and end of IV therapy.
Interventions
- OTHER Intervention N/A. Observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-12 |
What the finished NCT02684422 record still lists
NCT02684422 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intervention N/A. Observational study is the first listed.
NCT02684422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02684422 about?
NCT02684422 is a clinical study titled "Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)". This study aims to examine features of MRSA that are associated with chronic MRSA infection and bacterial persistence despite IV antibiotic therapy. Subjects are asked to expectorate sputum and complete CF symptom diaries both at beginning and end of IV therapy.
What is the current status of trial NCT02684422?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2015-07. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02684422?
The interventions under investigation include: Intervention N/A. Observational study (OTHER).
Who is sponsoring clinical trial NCT02684422?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia